Preoperative thrombocytosis is associated with survival after surgery for colorectal cancer

J Surg Oncol. 2012 Dec;106(7):887-91. doi: 10.1002/jso.23163. Epub 2012 May 23.

Abstract

Objective: To evaluate the influence of preoperative thrombocytosis on survival after surgery in patients with colorectal cancer (CRC).

Methods: Four hundred fifty-three patients who had undergone CRC surgery were retrospectively identified from institutional database. On the basis of receiver operating characteristic (ROC) curve analysis, they were classified into two groups: group A, with a preoperative platelet count of ≤300 (×10(9) /L), and Group B, with a preoperative platelet count of >300 (×10(9) /L). Uni- and multivariate analyses were performed to evaluate the relationship to overall survival. Kaplan-Meier analysis and log rank test were used to compare the survival curves between groups A and B.

Results: There was a significant difference in overall survival between the two groups (P = 0.007). Multivariate analysis of selected preoperative clinicolaboratory characteristics showed that overall survival was associated with the platelet count (Group A/B) (odds ratio, 1.642; 95% CI, 1.025-2.629; P = 0.039) as well as the number of tumors (1/≥2), and the serum levels of C-reactive protein (CRP) and carcinoembryonic antigen (CEA).

Conclusion: Preoperative thrombocytosis is associated with survival after surgery in CRC patients, and is able to divide such patients into two independent groups before surgery.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Colorectal Neoplasms / blood
  • Colorectal Neoplasms / mortality*
  • Colorectal Neoplasms / surgery*
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Platelet Count
  • ROC Curve
  • Retrospective Studies
  • Survival Rate
  • Thrombocytosis / complications*
  • Thrombocytosis / mortality
  • Thrombocytosis / pathology
  • Treatment Outcome